Shanghai, China

Yuxiu Qu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Jing Medicine Technology (Shanghai) Ltd., Shanghaitech University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuxiu Qu. Retrieved from https://idiyas.com/inventor/yuxiu-qu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuxiu Qu: Innovator in Pharmaceutical Compounds

Introduction

Yuxiu Qu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on EED inhibitors. His research and inventions have the potential to impact various therapeutic applications.

Latest Patents

Yuxiu Qu holds a patent for an EED inhibitor, along with its preparation method and use. The invention relates to a compound of formula (X) or its tautomer, stereoisomer, prodrug, crystal form, pharmaceutically acceptable salt, hydrate, or solvate. Additionally, it includes a pharmaceutical composition containing the compound and its various uses.

Career Highlights

Throughout his career, Yuxiu Qu has worked with prominent organizations, including Jing Medicine Technology (Shanghai) Ltd. and ShanghaiTech University. His experience in these institutions has allowed him to advance his research and collaborate with other experts in the field.

Collaborations

Yuxiu Qu has collaborated with notable colleagues, including Haizhen Zhang and Hui Lei. These partnerships have contributed to the development of his innovative ideas and research projects.

Conclusion

Yuxiu Qu is a distinguished inventor whose work on EED inhibitors showcases his commitment to advancing pharmaceutical science. His contributions are expected to have a lasting impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…